Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods – 8 March 2023

Administered by Department of Health, Disability and Ageing

Legislation au C2023G00315 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

Department of Health and Aged Care
Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

 

 

PUBLICATION OF LIST OF MANUFACTURERS REVOKED FROM LICENSING FOR

THE MANUFACTURE OF THERAPEUTIC GOODS – 8 March 2023

 

I, Katherine Clark, Delegate of the Secretary of the Department of Health and Aged Care, Therapeutic Goods Administration, for the purpose of Section 41 of the Therapeutic Goods Act 1989, hereby publish the following details concerning the revocation of a Licence to Manufacture Therapeutic Goods:

 

 

Under Section 41(1)(d) of the Therapeutic Goods Act 1989 the Secretary by notice in writing has revoked the Licence held by:

PureIV – LICENCE NO. MI-2019-LI-02208-1 OF 13a Bedbrook Place, Shenton Park, WA, 6008 – AT THE REQUEST OF THE MANUFACTURER.

Australian Red Cross Lifeblood - An Operating Division of The Australian Red Cross Society – LICENCE NO. MI-2017-LI-06919-1 OF Blood Donor Centre Hunter Street, Level 3 9 Hunter Street, SYDNEY, NSW, 2000 – AT THE REQUEST OF THE MANUFACTURER.

 

Pfizer australia pty ltd – LICENCE NO. MI-2014-LI-00757-1 OF level 3/500 collins street melbourne vic 3000 – AT THE REQUEST OF THE MANUFACTURER.



 

 

 

 

 

Signed by

 

Katherine Clark

Manufacturing Quality Branch

Delegate of the Secretary

8 March 2023

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.